Physician profile
Jacob K Thomas
NPI 1538328489
$6,211.42
in general payments reported to CMS, 2019-2025
19 companies · $1,055 in 2025
The $1,055 reported for 2025 was more than what 78% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,804 · 2020: $100 · 2021: $449 · 2022: $311 · 2023: $690 · 2024: $803 · 2025: $1,055.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,547.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $2,128.31 | 2019-2020 | |
| Abbvie INC. | $882.63 | 2023-2025 | Durysta, Alphagan P, Lumigan |
| Alcon Vision LLC | $673.74 | 2019-2025 | Clareon, Rocklatan, Acrysof Iq Panoptix Uv Iol |
| Regeneron Healthcare Solutions, INC. | $639.18 | 2019-2025 | Eylea Hd |
| Allergan, INC. | $320.85 | 2019-2021 | |
| Genentech USA, INC. | $289.67 | 2022-2025 | Vabysmo |
| Rxsight INC | $249.76 | 2023-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Glaukos Corporation | $240.07 | 2024-2025 | Istent Infinite, Idosetr, Idose |
| Bausch & Lomb Americas INC. | $211.84 | 2022-2025 | Ic-8 Apthera Iol, Miebo, Vyzulta |
| Sun Pharmaceutical Industries INC. | $147.85 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $122.22 | 2019-2020 | |
| Nova Eye, INC. | $106.66 | 2021 | |
| Novartis Pharmaceuticals Corporation | $79.30 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $24.80 | 2022 | |
| Oyster Point Pharma, INC. | $23.68 | 2023 | Tyrvaya |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $22.97 | 2023 | Iheezo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $20.05 | 2019 | |
| Ivantis, INC | $14.85 | 2020 | |
| Sight Sciences, INC. | $12.99 | 2023 | Omni Surgical System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.